Financhill
Back

Novo Nordisk AS 10K Form

Sell
32

NONOF
Novo Nordisk AS

Last Price:
105.43
Seasonality Move:
9.66%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive NONOF News And Ratings

See the #1 stock for the next 7 days that we like better than NONOF

NONOF Financial Statistics

Sales & Book Value

Annual Sales: $33.72B
Cash Flow: $4.75B
Price / Cash Flow: 49
Annual Sales: $4.06
Price / Book: 26.57

Profitability

EPS (TTM): 3.08600
Net Income (TTM): $13.79B
Gross Margin: $28.53B
Return on Equity: 88.95%
Return on Assets: 28.14%

Novo Nordisk AS Earnings Forecast

Key Novo Nordisk AS Financial Ratios

  • The Gross Profit Margin over the past 40 years for NONOF is 84.60%.
  • The Selling, General & Administrative Expenses for NONOF have been equal to 26.52% of Gross Profit Margin.
  • The Research & Development expenses have been 13.97% of Revenue.
  • The Interest Expense is 0.65% of Operating Income.
  • The Net Earning history of NONOF is 36.03% of Total Revenues.
  • Per Share Earnings over the last 40 years have been positive in 35 years.

Novo Nordisk AS Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: OTCM
Industry: Pharmaceuticals
Sector: Health Care
Current Symbol: NONOF
Website: novonordisk.com

Debt

Debt-to-Equity Ratio: 0.47
Current Ratio: 0.94
Quick Ratio: 0.74

Price-to-Earnings

Trailing P/E Ratio: 39.88
Forward P/E Ratio: 0

NONOF Technical Analysis vs Fundamental Analysis

Sell
32
Novo Nordisk AS (NONOF) is a Sell

Is Novo Nordisk AS a Buy or a Sell?

  • Novo Nordisk AS stock is rated a Sell
    The current Novo Nordisk AS [NONOF] share price is $107.81. The Score for NONOF is 32, which is 36% below its historic median score of 50, and infers higher risk than normal.